SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-072936
Filing Date
2023-06-20
Accepted
2023-06-20 16:44:35
Documents
13
Period of Report
2023-06-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319191d1_8k.htm   iXBRL 8-K 36793
2 EXHIBIT 3.1 tm2319191d1_ex3-1.htm EX-3.1 7498
  Complete submission text file 0001104659-23-072936.txt   223643

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acxp-20230615.xsd EX-101.SCH 3236
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acxp-20230615_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acxp-20230615_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2319191d1_8k_htm.xml XML 3718
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40536 | Film No.: 231025854
SIC: 2834 Pharmaceutical Preparations